 
MAINE STATE LEGISLATURE  
 
 
 
The following document is provided by the 
LAW AND LEGISLATIVE DIGITAL LIBRARY  
at the Maine State Law and Legislative Reference Library 
http://legislature.m aine.gov/lawlib 
 
 
 
 
 
 
 
 
 
 
Reproduced from scanned originals with text recognition applied 
(searchable text may contain so me errors and/or omissions) 
 
 
2 Date: 5/2.0/"S" MAJORITY 
L.D.289 
(Filing No. s-IDLi ) 
3 INSURANCE AND FINANCIAL SERVICES 
4 Reproduced and distributed under the direction of the Secretary of the Senate. 
5 STATE OF MAINE 
6 SENATE 
7 127TH LEGISLATURE 
8 FIRST REGULAR SESSION 
9 COMMITTEE AMENDMENT" A " to S.P. 103, L.D. 289, Bill, "An Act To 
10 Amend the Health Plan Improvement Law Regarding Prescription Drug Step Therapy" 
II Amend the bill in section I by striking out all of subsection I-A (page 1, lines 3 to 19 
12 in L.D.) and inserting the following: 
13 It_A. Prescription drug step therapy. The clinical review criteria used by a carrier 
14 in approving prescription drugs: 
15 A. May not prevent a health care practitioner from prescribing a medication for an 
16 off-label use; 
17 B. May not require failure on the same medication on more than one occasion for 
18 patients continuously enrolled in a health plan offered by the carrier; and 
19 C. May not prevent a health care practitioner from prescribing a medication on more 
20 than one occasion when the health care practitioner determines it is medically 
21 appropriate. 
22 A carrier may not require failure on one or more drugs as a condition of prior 
23 authorization for a nonpreferred drug unless an enrollee has affIrmatively agreed to the 
24 condition each time a carrier seeks to impose such a condition. Nothing in this subsection 
25 may be construed to prevent a carrier from collecting tiered copayments from enrollees 
26 not subject to the prior authorization requirements set forth in this subsection.' 
27 SUMMARY 
28 This amendment, which is the majority report of the committee, replaces the bill. The 
29 amendment provides that the clinical review criteria used by a carrier in approving 
30 prescription drugs may not prevent a health care practitioner from prescribing a 
31 medication for an off-label use, may not require failure on the same medication on more 
32 than one occasion for enrollees continuously enrolled in a health plan offered by the 
33 carrier and may not prevent a health care practitioner from prescribing a medication on 
34 more than one occasion when the health care practitioner determines it is medically 
35 appropriate. 
Page 1 -127LRl723(02)-1 
COMMITTEE AMENDMENT 
I 
2 
3 
4 
5 
6 COMMITTEE AMENDMENT" A " to S.P. 103, L.D. 289 
The amendment also prohibits a carrier from requiring the failure on one or more 
drugs as a condition of prior authorization for a nonpreferred drug unless an enrollee has 
affirmatively agreed to the condition each time a carrier seeks to impose such a condition. 
The amendment does not restrict the cost-sharing imposed by a carrier. 
FISCAL NOTE REQUIRED 
(See attached) 
Page 2 -12 7LRI723( 02)-1 
COMMITTEE AMENDMENT 
Revised: 05115115 ;!;?ac 
127th MAINE LEGISLATURE 
LD289 LR 1723(02) 
An Act To Amend the Health Plan Improvement Law Regarding Prescription Drug Step Therapy 
Fiscal Note for Bill as Amended by Committee Amendment "tÂ¥{S-1 OLi) 
Committee: Insurance and Financial Services 
Fiscal Note Required: Yes 
Fiscal Note 
Minor cost increase -Other Special Revenue Funds 
Fiscal Detail and Notes 
Any additional costs to the Department of Professional and Financial Regulation to adopt the changes in this bill are 
expected to be minor and can be absorbed within existing budgeted resources. 
LRI723(02) -Fiscal Note -Page I of I 
